Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Rajkumar

Showing results (111-120 of 773) with videos related to

Pageof 78
Sort By:
Best Practice & Research. Clinical Haematology|July 20, 2005
Monoclonal gammopathies of undetermined significanceRobert A Kyle, S Vincent Rajkumar
Clinical Lymphoma & Myeloma|October 20, 2005
Monoclonal gammopathy of undetermined significanceRobert A Kyle, S Vincent Rajkumar
European Journal of Haematology|September 17, 2013
Diagnostic evaluation of monoclonal gammopathy of undetermined significanceArchana M Rajan, S Vincent Rajkumar
Blood|November 30, 2017
How I manage monoclonal gammopathy of undetermined significanceRonald S Go, S Vincent Rajkumar
Blood|October 16, 2016
Next-generation multiple myeloma treatment: a pharmacoeconomic perspectiveS Vincent Rajkumar, Jean Luc Harousseau
The Lancet. Oncology|April 30, 2026
CAR T-cell therapy at first relapse in myelomaJowon Laura Kim, S Vincent Rajkumar
Mayo Clinic Proceedings|August 18, 2010
Prevalence of monoclonal gammopathy of undetermined significance: a systematic reviewRishi K Wadhera, S Vincent Rajkumar
Current Hematologic Malignancy Reports|April 29, 2010
Monoclonal gammopathy of undetermined significance and smoldering multiple myelomaRobert A Kyle, S Vincent Rajkumar
Reviews in Clinical and Experimental Hematology|March 6, 2003
Monoclonal gammopathies of undetermined significanceRobert A Kyle, S Vincent Rajkumar
British Journal of Haematology|August 30, 2006
Monoclonal gammopathy of undetermined significanceRobert A Kyle, S Vincent Rajkumar
Pageof 78

Showing results (111-120 of 773) with videos related to

Sort By:
Pageof 78
Best Practice & Research. Clinical Haematology|July 20, 2005
Monoclonal gammopathies of undetermined significanceRobert A Kyle, S Vincent Rajkumar
Clinical Lymphoma & Myeloma|October 20, 2005
Monoclonal gammopathy of undetermined significanceRobert A Kyle, S Vincent Rajkumar
European Journal of Haematology|September 17, 2013
Diagnostic evaluation of monoclonal gammopathy of undetermined significanceArchana M Rajan, S Vincent Rajkumar
Blood|November 30, 2017
How I manage monoclonal gammopathy of undetermined significanceRonald S Go, S Vincent Rajkumar
Blood|October 16, 2016
Next-generation multiple myeloma treatment: a pharmacoeconomic perspectiveS Vincent Rajkumar, Jean Luc Harousseau
The Lancet. Oncology|April 30, 2026
CAR T-cell therapy at first relapse in myelomaJowon Laura Kim, S Vincent Rajkumar
Mayo Clinic Proceedings|August 18, 2010
Prevalence of monoclonal gammopathy of undetermined significance: a systematic reviewRishi K Wadhera, S Vincent Rajkumar
Current Hematologic Malignancy Reports|April 29, 2010
Monoclonal gammopathy of undetermined significance and smoldering multiple myelomaRobert A Kyle, S Vincent Rajkumar
Reviews in Clinical and Experimental Hematology|March 6, 2003
Monoclonal gammopathies of undetermined significanceRobert A Kyle, S Vincent Rajkumar
British Journal of Haematology|August 30, 2006
Monoclonal gammopathy of undetermined significanceRobert A Kyle, S Vincent Rajkumar
Pageof 78